US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ArriVent BioPharma

15.09

-13.3700-46.98%

Pre-market: 14.53-0.5600-3.71%06:12 EDT

Volume:19.75M

Turnover:262.99M

Market Cap:744.05M

PE:-4.08

High:15.79

Open:12.09

Low:11.36

Close:28.46

52wk High:35.83

52wk Low:11.36

Shares:49.31M

Float Shares:32.11M

Volume Ratio:32.00

T/O Rate:61.52%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.6975

EPS(LYR):-4.3239

ROE:-53.25%

ROA:-33.11%

PB:2.03

PE(LYR):-3.49

Loading ...

Overview Company News Filings

Arrivent Biopharma - Clinical Benefit Observed with Secondary Endpoints Including Pfs and Confirmed Orr

THOMSON REUTERS

Arrivent Announces Program Update from the Phase 3 Furvent Trial of Firmonertinib in First-Line Egfr Exon 20 Insertion Mutant Nsclc

THOMSON REUTERS

NASDAQ Trade Halt Halt News Pending at 07:55 Am

ArriVent BioPharma, Inc. (AVBP) Gets a Buy from Guggenheim

Analysts Offer Insights on Healthcare Companies: Cellectis SA (CLLS) and ArriVent BioPharma, Inc. (AVBP)

Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), ArriVent BioPharma, Inc. (AVBP)

ArriVent’s ARR-002 Moves Forward in Early Ovarian and Endometrial Cancer Study

Arrivent Biopharma, Inc. : H.c. Wainwright Raises Target Price to $47 from $44

THOMSON REUTERS

U.S. Research Roundup- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies

ArriVent BioPharma (AVBP) Could Be 56% Undervalued After The Allist China Licensing Deal

Simply Wall St.

ArriVent BioPharma: Pipeline Progress and Funding Strength Support Buy Rating and Unchanged $42 Price Target

ArriVent BioPharma Price Target Maintained with a $42.00/Share by BTIG

ArriVent BioPharma, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

ArriVent Biopharma Releases Corporate Presentation on Late-Stage Oncology Pipeline Led by Firmonertinib in EGFR-Mutant NSCLC

ArriVent inks China partnership for ARR-002 development

ArriVent BioPharma Q2 EPS $(1.05) Misses $(0.99) Estimate

Benzinga Earnings

Press Release: ArriVent BioPharma Reports Second Quarter 2026 Financial Results

Analysts Are Bullish on These Healthcare Stocks: Astrana Health (ASTH), ArriVent BioPharma, Inc. (AVBP)

ArriVent BioPharma Stockholders Back Board and Auditor Slate

ArriVent Biopharma shareholders elect Class II directors at annual meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sgp.itiger.com/stock/AVBP/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVBP\",,,,,undefined,":{"symbol":"AVBP","market":"US","secType":"STK","nameCN":"ArriVent BioPharma","latestPrice":15.09,"timestamp":1791316800000,"preClose":28.46,"halted":0,"volume":19752235,"hourTrading":{"tag":"盘前","latestPrice":14.53,"preClose":15.09,"latestTime":"06:12 EDT","volume":2981,"amount":44040.378833,"timestamp":1791367940702,"change":-0.56,"changeRate":-0.037111,"amplitude":0.031127},"delay":0,"changeRate":-0.4697821503865074,"floatShares":32106300,"shares":49307729,"eps":-3.697539,"marketStatus":"Pre-Mkt","change":-13.37,"latestTime":"10-07 06:16:52 EDT","open":12.09,"high":15.79,"low":11.36,"amount":262990797.119505,"amplitude":0.155657,"askPrice":16.27,"askSize":100,"bidPrice":14.5,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-3.697539,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791379800000},"marketStatusCode":1,"adr":0,"listingDate":1706245200000,"exchange":"NASDAQ","adjPreClose":15.09,"preHourTrading":{"tag":"盘前","latestPrice":14.53,"preClose":15.09,"latestTime":"06:12 EDT","volume":2981,"amount":44040.378833,"timestamp":1791367940702,"change":-0.56,"changeRate":-0.037111,"amplitude":0.031127},"postHourTrading":{"tag":"盘后","latestPrice":14.9353,"preClose":15.09,"latestTime":"19:59 EDT","volume":44513,"amount":664290.4969,"timestamp":1791331195934,"change":-0.1547,"changeRate":-0.010252,"amplitude":0.035785},"volumeRatio":31.996669167965994,"optionData":{"bulkOrders":[{"symbol":"AVBP","call":true,"expireDate":1792123200000,"strike":"25.0","timestamp":1791303453054,"price":0.05,"volume":2000,"amount":10000,"type":"*"},{"symbol":"AVBP","call":true,"expireDate":1792123200000,"strike":"20.0","timestamp":1791303453054,"price":0.06,"volume":2000,"amount":12000,"type":"-"}]},"impliedVol":1.0485,"impliedVolPercentile":0.328},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVBP\",,,,,undefined,":{"symbol":"AVBP","floatShares":32106300,"roa":"-33.11%","roe":"-53.25%","lyrEps":-4.323888,"volumeRatio":31.996669167965994,"shares":49307729,"dividePrice":0,"high":15.79,"amplitude":0.155657,"preClose":28.46,"low":11.36,"week52Low":11.36,"pbRate":"2.03","week52High":35.83,"institutionHeld":0,"latestPrice":15.09,"committee":0.333333,"eps":-3.697539,"divideRate":0,"volume":19752235,"delay":0,"ttmEps":-3.697539,"open":12.09,"prevYearClose":20.12,"prevWeekClose":28.27,"prevMonthClose":30.28,"prevQuarterClose":30.28,"fiveDayClose":29.54,"twentyDayClose":30.28,"sixtyDayClose":33.64},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVBP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"AVBP","fiscalQuarterEnding":"2026/06","expectedEps":-0.98,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-1.05},{"market":"US","date":"2026-05-11","symbol":"AVBP","fiscalQuarterEnding":"2026/03","expectedEps":-0.88,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"post","actualEps":-0.96},{"market":"US","date":"2026-03-05","symbol":"AVBP","fiscalQuarterEnding":"2025/12","expectedEps":-0.87,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-0.78},{"market":"US","date":"2025-11-10","symbol":"AVBP","fiscalQuarterEnding":"2025/09","expectedEps":-0.78,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.83},{"market":"US","date":"2025-08-11","symbol":"AVBP","fiscalQuarterEnding":"2025/06","expectedEps":-0.7,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-0.9}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVBP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4167,"buy":0.5833,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5833,"analysts":12,"updateTime":1766462400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AVBP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AVBP","date":"2026-10-05","current":-4.081093,"percent":0.494656,"low":-15.980041,"twenty":-10.960617,"median":-8.452954,"eighty":-6.06248,"high":-4.80343,"avg":-8.593266,"sd":2.426123,"marketCap":1393929498},"quantilePoints":[{"date":"2024-01-26","current":-15.452095,"twenty":-15.452095,"median":-15.452095,"eighty":-15.452095,"marketCap":905214654},{"date":"2024-02-02","current":-11.990156,"twenty":-12.001066,"median":-11.872873,"eighty":-10.91006,"marketCap":702407320},{"date":"2024-02-09","current":-12.548731,"twenty":-12.548731,"median":-12.001066,"eighty":-11.75559,"marketCap":735129780},{"date":"2024-02-16","current":-12.588659,"twenty":-12.548731,"median":-12.126596,"eighty":-11.919241,"marketCap":737468829},{"date":"2024-02-23","current":-11.219707,"twenty":-12.556717,"median":-11.998256,"eighty":-11.67237,"marketCap":657272853},{"date":"2024-03-01","current":-12.286349,"twenty":-12.548731,"median":-11.990156,"eighty":-11.204877,"marketCap":719758884},{"date":"2024-03-08","current":-11.464977,"twenty":-12.548731,"median":-11.964074,"eighty":-11.315533,"marketCap":671641299},{"date":"2024-03-15","current":-10.59227,"twenty":-12.5031,"median":-11.767288,"eighty":-11.121598,"marketCap":620516364},{"date":"2024-03-22","current":-10.386927,"twenty":-12.327418,"median":-11.658912,"eighty":-10.920492,"marketCap":608486967},{"date":"2024-03-28","current":-10.267144,"twenty":-12.279504,"median":-11.507757,"eighty":-10.718898,"marketCap":601469820},{"date":"2024-04-05","current":-8.84046,"twenty":-12.261251,"median":-11.265338,"eighty":-10.410884,"marketCap":612935625},{"date":"2024-04-12","current":-8.536116,"twenty":-12.10149,"median":-11.165519,"eighty":-9.961411,"marketCap":591834562},{"date":"2024-04-19","current":-7.487821,"twenty":-11.997694,"median":-11.025772,"eighty":-8.805678,"marketCap":519153125},{"date":"2024-04-26","current":-7.507145,"twenty":-11.992272,"median":-10.91658,"eighty":-8.501334,"marketCap":520492875},{"date":"2024-05-03","current":-8.115832,"twenty":-11.986485,"median":-10.803317,"eighty":-8.191193,"marketCap":562695000},{"date":"2024-05-10","current":-8.079495,"twenty":-11.960082,"median":-10.543786,"eighty":-8.115832,"marketCap":602552562},{"date":"2024-05-17","current":-9.049573,"twenty":-11.929189,"median":-10.386927,"eighty":-8.101297,"marketCap":674899062},{"date":"2024-05-24","current":-8.479203,"twenty":-11.828069,"median":-10.210104,"eighty":-8.115832,"marketCap":632362000},{"date":"2024-05-31","current":-8.739687,"twenty":-11.762609,"median":-9.361752,"eighty":-8.133223,"marketCap":651788375},{"date":"2024-06-07","current":-8.241175,"twenty":-11.7192,"median":-8.959751,"eighty":-8.180566,"marketCap":614610312},{"date":"2024-06-14","current":-8.456747,"twenty":-11.662334,"median":-8.912923,"eighty":-8.216398,"marketCap":630687312},{"date":"2024-06-21","current":-7.455231,"twenty":-11.653208,"median":-8.84046,"eighty":-8.15931,"marketCap":555996250},{"date":"2024-06-28","current":-7.81452,"twenty":-11.61214,"median":-8.79358,"eighty":-8.133223,"marketCap":582791250},{"date":"2024-07-05","current":-8.205246,"twenty":-11.533425,"median":-8.753505,"eighty":-8.152944,"marketCap":611930812},{"date":"2024-07-12","current":-8.268121,"twenty":-11.43988,"median":-8.706383,"eighty":-8.152944,"marketCap":616619937},{"date":"2024-07-15","current":-8.259139,"twenty":-11.414782,"median":-8.695535,"eighty":-8.154535,"marketCap":615950062},{"date":"2024-08-02","current":-9.655872,"twenty":-11.389685,"median":-8.706383,"eighty":-8.156127,"marketCap":720115625},{"date":"2024-08-09","current":-10.262171,"twenty":-11.294999,"median":-8.753505,"eighty":-8.186872,"marketCap":765332187},{"date":"2024-08-16","current":-10.701201,"twenty":-11.237959,"median":-8.81702,"eighty":-8.205246,"marketCap":801359406},{"date":"2024-08-23","current":-10.705686,"twenty":-11.199173,"median":-8.912923,"eighty":-8.209568,"marketCap":801695265},{"date":"2024-08-30","current":-12.010819,"twenty":-11.389685,"median":-8.993434,"eighty":-8.224295,"marketCap":899430214},{"date":"2024-09-06","current":-11.93009,"twenty":-11.657877,"median":-9.253918,"eighty":-8.235785,"marketCap":893384753},{"date":"2024-09-13","current":-10.669806,"twenty":-11.694732,"median":-9.655872,"eighty":-8.248361,"marketCap":799008394},{"date":"2024-09-20","current":-10.85369,"twenty":-11.663166,"median":-9.763659,"eighty":-8.262732,"marketCap":812778610},{"date":"2024-09-27","current":-10.544226,"twenty":-11.657877,"median":-10.060071,"eighty":-8.269917,"marketCap":789604344},{"date":"2024-10-04","current":-11.49056,"twenty":-11.61214,"median":-10.208101,"eighty":-8.279798,"marketCap":860470578},{"date":"2024-10-11","current":-12.463804,"twenty":-11.739278,"median":-10.315491,"eighty":-8.299559,"marketCap":933351966},{"date":"2024-10-18","current":-13.002004,"twenty":-11.938503,"median":-10.371883,"eighty":-8.317243,"marketCap":973655038},{"date":"2024-10-25","current":-13.912458,"twenty":-11.99333,"median":-10.426855,"eighty":-8.325491,"marketCap":1041834400},{"date":"2024-10-31","current":-14.114283,"twenty":-12.114871,"median":-10.539741,"eighty":-8.328911,"marketCap":1056948052},{"date":"2024-11-08","current":-15.980041,"twenty":-12.249611,"median":-10.573379,"eighty":-8.330997,"marketCap":1196665367},{"date":"2024-11-15","current":-11.674764,"twenty":-12.282511,"median":-10.59227,"eighty":-8.332793,"marketCap":946216280},{"date":"2024-11-22","current":-11.05527,"twenty":-12.272349,"median":-10.669806,"eighty":-8.342492,"marketCap":896007510},{"date":"2024-11-29","current":-12.456408,"twenty":-12.274941,"median":-10.685503,"eighty":-8.352544,"marketCap":1009566943},{"date":"2024-12-06","current":-11.870175,"twenty":-12.284404,"median":-10.712096,"eighty":-8.353452,"marketCap":962053946},{"date":"2024-12-13","current":-10.760075,"twenty":-12.274941,"median":-10.748293,"eighty":-8.371867,"marketCap":872082526},{"date":"2024-12-20","current":-10.664448,"twenty":-12.261979,"median":-10.759506,"eighty":-8.380399,"marketCap":864332179},{"date":"2024-12-27","current":-11.46688,"twenty":-12.254096,"median":-10.803317,"eighty":-8.380399,"marketCap":929367700},{"date":"2025-01-03","current":-11.421146,"twenty":-12.244582,"median":-10.85369,"eighty":-8.380399,"marketCap":925661012},{"date":"2025-01-10","current":-11.167527,"twenty":-12.234172,"median":-10.860965,"eighty":-8.382195,"marketCap":905105744},{"date":"2025-01-17","current":-10.177999,"twenty":-12.217129,"median":-10.850538,"eighty":-8.390279,"marketCap":824906501},{"date":"2025-01-24","current":-11.329677,"twenty":-12.196013,"median":-10.850538,"eighty":-8.405549,"marketCap":918247637},{"date":"2025-01-31","current":-12.09469,"twenty":-12.164539,"median":-10.860965,"eighty":-8.437266,"marketCap":980250413},{"date":"2025-02-07","current":-11.383727,"twenty":-12.161213,"median":-10.897572,"eighty":-8.450678,"marketCap":922628268},{"date":"2025-02-14","current":-11.16337,"twenty":-12.157147,"median":-10.9231,"eighty":-8.461238,"marketCap":904768772},{"date":"2025-02-21","current":-11.387884,"twenty":-12.140884,"median":-10.92545,"eighty":-8.479203,"marketCap":922965239},{"date":"2025-02-28","current":-9.8537,"twenty":-12.107163,"median":-10.91658,"eighty":-8.519623,"marketCap":798622715},{"date":"2025-03-07","current":-9.217439,"twenty":-12.09469,"median":-10.885085,"eighty":-8.536116,"marketCap":741893256},{"date":"2025-03-14","current":-9.192082,"twenty":-12.065586,"median":-10.857328,"eighty":-8.618427,"marketCap":739852284},{"date":"2025-03-21","current":-8.258082,"twenty":-12.010819,"median":-10.847386,"eighty":-8.519623,"marketCap":664676489},{"date":"2025-03-28","current":-7.848136,"twenty":-12.001066,"median":-10.781696,"eighty":-8.449161,"marketCap":631680778},{"date":"2025-04-04","current":-7.159258,"twenty":-11.995446,"median":-10.737081,"eighty":-8.380399,"marketCap":576234377},{"date":"2025-04-11","current":-7.125448,"twenty":-11.990156,"median":-10.711139,"eighty":-8.353452,"marketCap":573513081},{"date":"2025-04-17","current":-7.564978,"twenty":-11.988746,"median":-10.703443,"eighty":-8.330997,"marketCap":608889926},{"date":"2025-04-25","current":-8.94696,"twenty":-11.984909,"median":-10.669806,"eighty":-8.330476,"marketCap":720122890},{"date":"2025-05-02","current":-8.908923,"twenty":-11.976101,"median":-10.6604,"eighty":-8.330997,"marketCap":717061432},{"date":"2025-05-09","current":-8.353948,"twenty":-11.95416,"median":-10.580862,"eighty":-8.330997,"marketCap":672392561},{"date":"2025-05-16","current":-5.164444,"twenty":-11.945123,"median":-10.566696,"eighty":-8.323142,"marketCap":658249673},{"date":"2025-05-23","current":-5.537551,"twenty":-11.932894,"median":-10.539741,"eighty":-8.281274,"marketCap":705805133},{"date":"2025-05-30","current":-5.636867,"twenty":-11.923581,"median":-10.506711,"eighty":-8.258716,"marketCap":718463781},{"date":"2025-06-06","current":-6.29987,"twenty":-11.889801,"median":-10.45834,"eighty":-8.241176,"marketCap":802968806},{"date":"2025-06-13","current":-6.342817,"twenty":-11.86768,"median":-10.37894,"eighty":-8.205246,"marketCap":808442816},{"date":"2025-06-20","current":-6.681029,"twenty":-11.831093,"median":-10.360937,"eighty":-8.13004,"marketCap":851550643},{"date":"2025-06-27","current":-6.122711,"twenty":-11.774139,"median":-10.336565,"eighty":-8.056606,"marketCap":780388516},{"date":"2025-07-03","current":-5.951741,"twenty":-11.764948,"median":-10.291317,"eighty":-8.012114,"marketCap":758596999},{"date":"2025-07-11","current":-6.3128,"twenty":-11.752729,"median":-10.177999,"eighty":-7.877518,"marketCap":804616846},{"date":"2025-07-18","current":-6.510523,"twenty":-11.737545,"median":-10.15098,"eighty":-7.814365,"marketCap":829818191},{"date":"2025-07-25","current":-6.146598,"twenty":-11.721024,"median":-10.060071,"eighty":-7.74746,"marketCap":783433107},{"date":"2025-08-01","current":-5.590682,"twenty":-11.706801,"median":-9.819907,"eighty":-7.667253,"marketCap":712577152},{"date":"2025-08-08","current":-5.312724,"twenty":-11.672734,"median":-9.759167,"eighty":-7.57343,"marketCap":677149175},{"date":"2025-08-15","current":-5.522288,"twenty":-11.663891,"median":-9.64689,"eighty":-7.464633,"marketCap":755393737},{"date":"2025-08-22","current":-5.895976,"twenty":-11.659587,"median":-9.496371,"eighty":-7.205647,"marketCap":806510606},{"date":"2025-08-29","current":-5.697269,"twenty":-11.653822,"median":-9.38434,"eighty":-6.898922,"marketCap":779329414},{"date":"2025-09-05","current":-5.789208,"twenty":-11.653208,"median":-9.260758,"eighty":-6.705187,"marketCap":791905786},{"date":"2025-09-12","current":-5.640919,"twenty":-11.550537,"median":-9.192082,"eighty":-6.342817,"marketCap":771621314},{"date":"2025-09-19","current":-5.510425,"twenty":-11.49056,"median":-9.038346,"eighty":-6.3128,"marketCap":753770979},{"date":"2025-09-26","current":-5.092249,"twenty":-11.46688,"median":-8.984996,"eighty":-6.266951,"marketCap":696568768},{"date":"2025-10-03","current":-5.584569,"twenty":-11.464977,"median":-8.939882,"eighty":-6.203238,"marketCap":763913215},{"date":"2025-10-10","current":-6.266699,"twenty":-11.458565,"median":-8.908923,"eighty":-6.178119,"marketCap":857221786},{"date":"2025-10-17","current":-5.820349,"twenty":-11.441934,"median":-8.860202,"eighty":-6.17476,"marketCap":796165526},{"date":"2025-10-24","current":-5.365101,"twenty":-11.433619,"median":-8.84046,"eighty":-6.120027,"marketCap":733892196},{"date":"2025-10-31","current":-5.477801,"twenty":-11.433619,"median":-8.796928,"eighty":-6.098553,"marketCap":749308395},{"date":"2025-11-07","current":-5.454075,"twenty":-11.421146,"median":-8.757651,"eighty":-5.987916,"marketCap":746062880},{"date":"2025-11-14","current":-5.38103,"twenty":-11.41283,"median":-8.728459,"eighty":-5.931566,"marketCap":812417184},{"date":"2025-11-21","current":-5.484932,"twenty":-11.400357,"median":-8.689159,"eighty":-5.895976,"marketCap":828104101},{"date":"2025-11-28","current":-6.2724,"twenty":-11.397031,"median":-8.627903,"eighty":-5.884113,"marketCap":946994421},{"date":"2025-12-05","current":-6.657931,"twenty":-11.389547,"median":-8.556032,"eighty":-5.884113,"marketCap":1005201140},{"date":"2025-12-12","current":-6.649728,"twenty":-11.384558,"median":-8.523142,"eighty":-5.893603,"marketCap":1003962699},{"date":"2025-12-19","current":-5.788435,"twenty":-11.375905,"median":-8.467975,"eighty":-5.893603,"marketCap":873926412},{"date":"2025-12-26","current":-6.094673,"twenty":-11.359859,"median":-8.441726,"eighty":-5.901564,"marketCap":920161536},{"date":"2026-01-02","current":-5.501338,"twenty":-11.346075,"median":-8.391627,"eighty":-5.884113,"marketCap":830580983},{"date":"2026-01-09","current":-5.364625,"twenty":-11.337228,"median":-8.380399,"eighty":-5.844354,"marketCap":809940302},{"date":"2026-01-16","current":-5.988037,"twenty":-11.332171,"median":-8.373482,"eighty":-5.835858,"marketCap":904061805},{"date":"2026-01-23","current":-6.890344,"twenty":-11.326351,"median":-8.3537,"eighty":-5.833294,"marketCap":1040290297},{"date":"2026-01-30","current":-6.152093,"twenty":-11.304731,"median":-8.339979,"eighty":-5.843953,"marketCap":928830622},{"date":"2026-02-06","current":-5.837652,"twenty":-11.270243,"median":-8.329694,"eighty":-5.843953,"marketCap":881357057},{"date":"2026-02-13","current":-6.130218,"twenty":-11.263238,"median":-8.321475,"eighty":-5.843953,"marketCap":925528113},{"date":"2026-02-20","current":-6.313414,"twenty":-11.254838,"median":-8.290577,"eighty":-5.845558,"marketCap":953186625},{"date":"2026-02-27","current":-6.351694,"twenty":-11.246523,"median":-8.270367,"eighty":-5.848589,"marketCap":958966016},{"date":"2026-03-06","current":-6.710988,"twenty":-11.219707,"median":-8.258082,"eighty":-5.878182,"marketCap":1116090955},{"date":"2026-03-13","current":-6.40401,"twenty":-11.204946,"median":-8.245403,"eighty":-5.8814,"marketCap":1065038082},{"date":"2026-03-20","current":-6.07577,"twenty":-11.192473,"median":-8.232192,"eighty":-5.884113,"marketCap":1010449078},{"date":"2026-03-27","current":-5.79537,"twenty":-11.188316,"median":-8.205246,"eighty":-5.878182,"marketCap":963816367},{"date":"2026-04-02","current":-6.437233,"twenty":-11.18605,"median":-8.155331,"eighty":-5.851728,"marketCap":1070563284},{"date":"2026-04-10","current":-7.242551,"twenty":-11.184423,"median":-8.115832,"eighty":-5.873048,"marketCap":1204494199},{"date":"2026-04-17","current":-7.869796,"twenty":-11.184158,"median":-8.05762,"eighty":-5.880756,"marketCap":1308810027},{"date":"2026-04-24","current":-8.239233,"twenty":-11.170853,"median":-8.079495,"eighty":-5.88357,"marketCap":1370250282},{"date":"2026-05-01","current":-8.263153,"twenty":-11.164201,"median":-8.071094,"eighty":-5.884113,"marketCap":1374228427},{"date":"2026-05-08","current":-8.043687,"twenty":-11.160044,"median":-8.062693,"eighty":-5.892853,"marketCap":1337729551},{"date":"2026-05-15","current":-9.113539,"twenty":-11.148286,"median":-8.082287,"eighty":-5.895788,"marketCap":1323659453},{"date":"2026-05-22","current":-8.658182,"twenty":-11.130931,"median":-8.115832,"eighty":-5.903426,"marketCap":1257523056},{"date":"2026-05-29","current":-8.648562,"twenty":-11.121131,"median":-8.15931,"eighty":-5.909002,"marketCap":1256125808},{"date":"2026-06-05","current":-10.611083,"twenty":-11.112406,"median":-8.208286,"eighty":-5.914633,"marketCap":1541164367},{"date":"2026-06-12","current":-9.684337,"twenty":-11.089363,"median":-8.224914,"eighty":-5.923855,"marketCap":1406562825},{"date":"2026-06-18","current":-10.056318,"twenty":-11.074395,"median":-8.233917,"eighty":-5.929786,"marketCap":1460589742},{"date":"2026-06-26","current":-10.846778,"twenty":-11.071901,"median":-8.241176,"eighty":-5.939636,"marketCap":1575396939},{"date":"2026-07-02","current":-11.063233,"twenty":-11.071901,"median":-8.253856,"eighty":-5.951741,"marketCap":1606835016},{"date":"2026-07-10","current":-10.797074,"twenty":-11.071901,"median":-8.258372,"eighty":-5.954231,"marketCap":1568177825},{"date":"2026-07-17","current":-10.505261,"twenty":-11.071901,"median":-8.265637,"eighty":-5.966771,"marketCap":1525794641},{"date":"2026-07-24","current":-10.11404,"twenty":-11.070167,"median":-8.283439,"eighty":-5.979263,"marketCap":1468973229},{"date":"2026-07-31","current":-9.831847,"twenty":-11.063233,"median":-8.313032,"eighty":-5.987916,"marketCap":1427987292},{"date":"2026-08-07","current":-9.944083,"twenty":-11.060026,"median":-8.325975,"eighty":-5.988037,"marketCap":1444288517},{"date":"2026-08-14","current":-9.008172,"twenty":-11.059428,"median":-8.330997,"eighty":-5.993847,"marketCap":1479231870},{"date":"2026-08-21","current":-8.761948,"twenty":-11.05527,"median":-8.347715,"eighty":-5.99759,"marketCap":1438799532},{"date":"2026-08-28","current":-9.308444,"twenty":-11.025772,"median":-8.353948,"eighty":-6.007177,"marketCap":1528539599},{"date":"2026-09-04","current":-9.317452,"twenty":-11.021545,"median":-8.377748,"eighty":-6.007177,"marketCap":1530018830},{"date":"2026-09-11","current":-8.617818,"twenty":-11.020363,"median":-8.380399,"eighty":-6.015927,"marketCap":1415131822},{"date":"2026-09-18","current":-8.515725,"twenty":-11.011642,"median":-8.38489,"eighty":-6.022488,"marketCap":1398367194},{"date":"2026-09-25","current":-9.038199,"twenty":-11.006851,"median":-8.398491,"eighty":-6.041944,"marketCap":1484162642},{"date":"2026-10-02","current":-8.68688,"twenty":-10.96973,"median":-8.449161,"eighty":-6.059291,"marketCap":1426472599},{"date":"2026-10-05","current":-8.4887,"twenty":-10.960617,"median":-8.452954,"eighty":-6.06248,"marketCap":1393929498}],"updateTime":1791352904549},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVBP\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673056854","title":"Arrivent Biopharma - Clinical Benefit Observed with Secondary Endpoints Including Pfs and Confirmed Orr","url":"https://stock-news.laohu8.com/highlight/detail?id=2673056854","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673056854?lang=en_us&edition=fundamental","pubTime":"2026-10-06 20:00","pubTimestamp":1791288005,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nTUA87SF6V:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673055000","title":"Arrivent Announces Program Update from the Phase 3 Furvent Trial of Firmonertinib in First-Line Egfr Exon 20 Insertion Mutant Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2673055000","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673055000?lang=en_us&edition=fundamental","pubTime":"2026-10-06 20:00","pubTimestamp":1791288005,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nTUA87SF6V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AVBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673055721","title":"NASDAQ Trade Halt Halt News Pending at 07:55 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2673055721","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673055721?lang=en_us&edition=fundamental","pubTime":"2026-10-06 19:55","pubTimestamp":1791287700,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTHALT NEWS PENDING AT 07:55 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nAQN2MMZSQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AVBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667364430","title":"ArriVent BioPharma, Inc. (AVBP) Gets a Buy from Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2667364430","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667364430?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:35","pubTimestamp":1789472159,"startTime":"0","endTime":"0","summary":"In a report released today, Michael Schmidt from Guggenheim maintained a Buy rating on ArriVent BioPharma, Inc., with a price target of $45.00. Sch...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/arrivent-biopharma-inc-avbp-gets-a-buy-from-guggenheim-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/arrivent-biopharma-inc-avbp-gets-a-buy-from-guggenheim-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667703649","title":"Analysts Offer Insights on Healthcare Companies: Cellectis SA (CLLS) and ArriVent BioPharma, Inc. (AVBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667703649","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667703649?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:50","pubTimestamp":1789469407,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cellectis SA (CLLS) and ArriVent BioPharma, Inc. (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cellectis-sa-clls-and-arrivent-biopharma-inc-avbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cellectis-sa-clls-and-arrivent-biopharma-inc-avbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0128526141.USD","CLLS","BK4588","LABU","BK4585","AVBP","BK4581","XBI","HCSG","BK4137","LU0029874061.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667966776","title":"Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), ArriVent BioPharma, Inc. (AVBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667966776","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667966776?lang=en_us&edition=fundamental","pubTime":"2026-09-15 05:10","pubTimestamp":1789420212,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and ArriVent BioPharma, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-arrivent-biopharma-inc-avbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-arrivent-biopharma-inc-avbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJT1NW94.SGD","CANC","IE0009355771.USD","LU0128526141.USD","LU0029874061.USD","BK4585","HCSG","XBI","BK4139","IE00BFTCPJ56.SGD","RVMD","BK4137","LU0889565916.HKD","XLV","IDNA","IE00BJJMRZ35.SGD","BK4588","LABU","BK4581","AVBP","IE0009354923.USD","BBH","IE0002141913.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","PTH","LU0320765992.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664805870","title":"ArriVent’s ARR-002 Moves Forward in Early Ovarian and Endometrial Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2664805870","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664805870?lang=en_us&edition=fundamental","pubTime":"2026-09-04 00:32","pubTimestamp":1788453145,"startTime":"0","endTime":"0","summary":"ArriVent BioPharma, Inc. ($AVBP) announced an update on their ongoing clinical study. ArriVent BioPharma, Inc. is running a Phase 1 study of ARR-00...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arrivents-arr-002-moves-forward-in-early-ovarian-and-endometrial-cancer-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arrivents-arr-002-moves-forward-in-early-ovarian-and-endometrial-cancer-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4110","REM","ARR","AVBP","MORT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660489005","title":"Arrivent Biopharma, Inc. : H.c. Wainwright Raises Target Price to $47 from $44","url":"https://stock-news.laohu8.com/highlight/detail?id=2660489005","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660489005?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:17","pubTimestamp":1786961874,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nAZN4TES83:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660488079","title":"U.S. Research Roundup- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2660488079","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660488079?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:16","pubTimestamp":1786954612,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell TechnologiesAug 17 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4N44E0FK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXE","BMRN","AMAT","CCAP","TINY","CRWD","AVBP","DVN","EQT","FHLC","DLTR","EAT","BCSF","URAN","EOG","ELVN","COP","ELS","ESS","APA","DUK","TDV","CPT","BYND","AEP","CLYM","DNTH","PXE","XLE","ABBV","RSPS","DAVE","DELL","ALAB","BILT","AHR","CVX","FANG","AMLX","TGT","DCH","RDVY","HON","CHRD","APP","AMTM","CBRE","CHPS","AVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659747011","title":"ArriVent BioPharma (AVBP) Could Be 56% Undervalued After The Allist China Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2659747011","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659747011?lang=en_us&edition=fundamental","pubTime":"2026-08-16 17:21","pubTimestamp":1786872091,"startTime":"0","endTime":"0","summary":"ArriVent BioPharma (AVBP) drew fresh attention after granting Shanghai Allist Pharmaceuticals exclusive rights to develop and commercialize its antibody drug conjugate ARR-002 in Greater China in return for upfront, milestone, and royalty payments.\nSee our latest analysis for ArriVent BioPharma.\nAgainst this licensing backdrop, ArriVent BioPharma’s share price has eased in the short term, with a 1-day share price return of 1.63% down, a 7-day return of 4.31% down, and a 30-day return of...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-avbp/arrivent-biopharma/news/arrivent-biopharma-avbp-could-be-56-undervalued-after-the-al","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-avbp/arrivent-biopharma/news/arrivent-biopharma-avbp-could-be-56-undervalued-after-the-al","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AVBP","BK4139","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659715537","title":"ArriVent BioPharma: Pipeline Progress and Funding Strength Support Buy Rating and Unchanged $42 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2659715537","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659715537?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:36","pubTimestamp":1786617405,"startTime":"0","endTime":"0","summary":"Analyst Jeet Mukherjee from BTIG maintained a Buy rating on ArriVent BioPharma, Inc. and keeping the price target at $42.00. Jeet Mukherjee has giv...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/arrivent-biopharma-pipeline-progress-and-funding-strength-support-buy-rating-and-unchanged-42-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/arrivent-biopharma-pipeline-progress-and-funding-strength-support-buy-rating-and-unchanged-42-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVBP","PRGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659159153","title":"ArriVent BioPharma Price Target Maintained with a $42.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2659159153","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659159153?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:24","pubTimestamp":1786616640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AVBP/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659185956","title":"ArriVent BioPharma, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659185956","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659185956?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:46","pubTimestamp":1786571217,"startTime":"0","endTime":"0","summary":"ArriVent BioPharma, Inc. reports results for the quarter ended June 30 - Earnings SummaryArriVent BioPharma, Inc.AVBP.OQreported a quarterly adjusted loss of $1.05 per share for the quarter ended June","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N44929U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659883071","title":"ArriVent Biopharma Releases Corporate Presentation on Late-Stage Oncology Pipeline Led by Firmonertinib in EGFR-Mutant NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2659883071","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659883071?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:36","pubTimestamp":1786567015,"startTime":"0","endTime":"0","summary":"ArriVent Biopharma releases corporate presentation on late-stage oncology pipeline led by firmonertinib in EGFR-mutant NSCLCArriVent highlighted firmonertinib as its lead program, targeting first-line","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL29B2M1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659188934","title":"ArriVent inks China partnership for ARR-002 development","url":"https://stock-news.laohu8.com/highlight/detail?id=2659188934","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659188934?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:30","pubTimestamp":1786566620,"startTime":"0","endTime":"0","summary":"ArriVent BioPharma, Inc. ( ($AVBP) ) just unveiled an update. On August 11, 2026, ArriVent BioPharma entered into an exclusive collaboration and li...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arrivent-inks-china-partnership-for-arr-002-development?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arrivent-inks-china-partnership-for-arr-002-development?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MORT","BK4110","BK4139","ARR","AVBP","REM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659258900","title":"ArriVent BioPharma Q2 EPS $(1.05) Misses $(0.99) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659258900","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659258900?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:17","pubTimestamp":1786565841,"startTime":"0","endTime":"0","summary":"ArriVent BioPharma (NASDAQ:AVBP) reported quarterly losses of $(1.05) per share which missed the analyst consensus estimate of $(0.99) by 6.06 percent. This is a 16.67 percent decrease over losses of $(0.90) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61159038/arrivent-biopharma-q2-eps-1-05-misses-0-99-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"ArriVent BioPharma Q2 EPS $(1.05) Misses $(0.99) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659074329","title":"Press Release: ArriVent BioPharma Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659074329","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659074329?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:01","pubTimestamp":1786564860,"startTime":"0","endTime":"0","summary":"-- Topline global pivotal Phase 3 data for firmonertinib in first-line EGFR. -- ARR-217, a CDH17 targeted ADC for gastrointestinal malignancies, advanced. -- Dosing of first patient with ARR-002, a dual-targeting MUC16/NaPi2b. tetravalent ADC with initial focus in ovarian and endometrial cancers. -- Cash and investments of $373.1 million as of June 30, 2026 expected to. Ongoing pivotal Phase 3 study in frontline EGFR exon 20 insertion mutant. NSCLC supported by preclinical data for EGFR inhibitor firmonertinib. showcased high resolution crystal structure data at the 2026 American. Association for Cancer Research  Annual Meeting.Pipeline-- Initiated Phase 1b Dose Optimization of ADC lead ARR-217 .ArriVent has initiated Phase 1b dose optimization for ARR-217, a CDH17. targeted ADC, in patients with gastrointestinal malignancies in. -- Clinically advancing ARR-002 in ovarian and endometrial cancer. ArriVent. the clinic through a first-in-human study evaluating safety, dosing, and. early s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRC","ADC","BK4080","BK4231","AVBP","LU0266512127.USD","LU0456854461.SGD","NETL","IND","BK4213","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651730174","title":"Analysts Are Bullish on These Healthcare Stocks: Astrana Health (ASTH), ArriVent BioPharma, Inc. (AVBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651730174","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651730174?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:20","pubTimestamp":1784024413,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Astrana Health (ASTH), ArriVent BioPharma, Inc. (AVB...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-astrana-health-asth-arrivent-biopharma-inc-avbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-astrana-health-asth-arrivent-biopharma-inc-avbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","AVBP","BK4139","ASTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645008960","title":"ArriVent BioPharma Stockholders Back Board and Auditor Slate","url":"https://stock-news.laohu8.com/highlight/detail?id=2645008960","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645008960?lang=en_us&edition=fundamental","pubTime":"2026-06-23 05:08","pubTimestamp":1782162509,"startTime":"0","endTime":"0","summary":"ArriVent BioPharma, Inc. ( ($AVBP) ) has provided an update. On June 18, 2026, ArriVent BioPharma, Inc. held its 2026 annual meeting of stockholder...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arrivent-biopharma-stockholders-back-board-and-auditor-slate?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arrivent-biopharma-stockholders-back-board-and-auditor-slate?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645077965","title":"ArriVent Biopharma shareholders elect Class II directors at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2645077965","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645077965?lang=en_us&edition=fundamental","pubTime":"2026-06-23 04:02","pubTimestamp":1782158527,"startTime":"0","endTime":"0","summary":"ArriVent BioPharma held its annual shareholder meeting on June 18, 2026.Shareholders backed the election of James Healy, John Hohneker, Stuart Lutzker as directors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ArriVent Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 22, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDLbTRLRs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AVBP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":68,"code":"91000000","status":"200"}]}}